DataMeds AI, Inc.
Wellgistics Health, Inc. (NASDAQ Capital Market) operates as a holding company building an integrated healthcare ecosystem focused on specialty-lite and niche pharmaceutical products and services. The company was incorporated in 2022 and conducts business through two wholly owned subsidiaries—Wood Sage LLC and… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What DataMeds AI, Inc. does
In the company’s own words
Wellgistics Health, Inc. (NASDAQ Capital Market) operates as a holding company building an integrated healthcare ecosystem focused on specialty-lite and niche pharmaceutical products and services. The company was incorporated in 2022 and conducts business through two wholly owned subsidiaries—Wood Sage LLC and Wellgistics LLC—along with two indirect subsidiaries: Alliance Pharma Solutions LLC, doing business as DelivMeds, and Community Specialty Pharmacy LLC, doing business as Wellgistics Pharmacy.
The company operates three primary business segments. Wellgistics Pharmacy, founded in 2011, functions as a retail community specialty pharmacy licensed in 32 states and the District of Columbia, providing general and specialty pharmacy services including patient care coordination, clinical services, compliance programs, patient financial assistance, prior authorization support, and REMS protocol administration. The pharmacy maintains operations in Tampa, Florida with a call center and customer support infrastructure.
Wellgistics LLC, established in 2013, operates as a 50-state FDA-licensed pharmaceutical wholesaler and third-party logistics provider serving over 5,000 registered pharmacies nationwide. The wholesale division maintains distribution centers in Lakeland, Florida and Columbus, Ohio, with a product portfolio comprising approximately 65 percent topical generics, 20 percent oral generics, 10 percent branded formulations, and 5 percent over-the-counter products. The division manages relationships with over 60 pharmaceutical manufacturers.
DelivMeds, founded in 2017 and recommissioned in 2020, provides a technology platform serving as a pharmaceutical hub and middleware connecting patients, providers, pharmacies, payors, and pharmaceutical manufacturers through its mobile application and clinical services. The platform facilitates prescription transfers, offers patient care coordination, benefits investigation, prior authorization support, and data analytics capabilities.
The company's integrated model leverages synergies across pharmacy operations, wholesale distribution, and technology to address medication adherence challenges, improve price transparency, and optimize patient outcomes across specialty-lite therapeutic categories. The business targets independent pharmacies, pharmaceutical manufacturers, healthcare providers, and payors seeking solutions to control drug spending and enhance clinical outcomes.
Company details
- Sector
- Consumer Discretionary
- Industry
- Wholesale
- Headquarters
- TAMPA, FL
- Fiscal year end
- December
- CIK
- 2030763
- SIC
- 5122
Financial performance, year by year
Fiscal 2024–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns DataMeds AI, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · DataMeds AI, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do DataMeds AI, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of DataMeds AI, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in DataMeds AI, Inc.'s last four quarterly filings that the numbers alone won't show?”